Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

FRONTIERS IN NEUROLOGY（2023）

Cited 2|Views7

No score

Abstract

GENERAL COMMENTARY article Front. Neurol., 16 March 2023Sec. Multiple Sclerosis and Neuroimmunology Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1146027

Translated text

Key words

progressive multifocal leucoencephalopathy (PML),multiple sclerosis,natalizumab,risk factors,immunogenetics

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined